Notably, patients receiving combination therapy (Group 3) exhibited the greatest improvement in oral health-related quality of life at week 4, as measured by the OHIP-14 K, compared to those in the liquid NAC monotherapy group (Group 1) and the clonazepam monotherapy group (Group 2)
A novel biosensor for reduced l-glutathione based on cobalt phthalocyaninetetrasulfonate-intercalated layered double hydroxide modified glassy carbon electrodes
These include metabolism regulation, stress responses, and aging biology
Furthermore, it is known that young organisms physiologically have more glutathione reserves than adults and that with aging these reserves are gradually depleted or reduced
Some patients report rapid improvements in speech, mobility, or alertness, though this treatment is not yet FDA-approved for stroke and remains controversial due to limited clinical evidence
Symptoms can range from mild skin reactions, such as hives, to more severe symptoms, like difficulty breathing